Market Place
Sourcing Support
Nusano And Starget Pharma Announce Radioligand Supply Agreement
17 Oct 2024 //
GLOBENEWSWIRE
Nusano Presenting at Industry Events in October
07 Oct 2024 //
GLOBENEWSWIRE
Nusano Expands Leadership Team Before 2025 Launch
03 Oct 2024 //
GLOBENEWSWIRE
Nusano Announces $115M Series C Financing for Radioisotopes
01 Oct 2024 //
GLOBENEWSWIRE
Nusano, PharmaLogic Enter Supply Agreement to Provide Critical Radioisotopes
10 Jul 2024 //
CONTRACT PHARMA
Nusano And PharmaLogic Form Strategic Radiopharmaceutical Supply Agreement
10 Jul 2024 //
PR NEWSWIRE
Nusano To Host Virtual Event "Office Hours: Radiopharmaceuticals" On June 28
20 Jun 2024 //
GLOBENEWSWIRE
Nusano Names D. Scott Holbrook as Chairman of its Board
07 Jun 2024 //
GLOBENEWSWIRE
Nusano Expands Mgmt Ahead Of Q1 2025 Radioisotope Commercialization
29 May 2024 //
GLOBENEWSWIRE
Nusano to Present at Jefferies Radiopharma Innovation Summit
10 Apr 2024 //
GLOBENEWSWIRE
Nusano to Present Isotope Production Capabilities and Commercialization Plans
20 Mar 2024 //
GLOBENEWSWIRE
Nusano Opens Radiochemistry Laboratory
11 Mar 2024 //
GLOBENEWSWIRE
Nusano to Participate in the B. Riley Securities Radiopharma Investor Conference
26 Feb 2024 //
GLOBENEWSWIRE
Nusano Names Rohan Jain as Commercial General Manager
22 Jan 2024 //
GLOBENEWSWIRE
Nusano to Host Virtual KOL Event on Emerging Trends in Radiotherapeutics
12 Dec 2023 //
GLOBENEWSWIRE
Nusano to Participate in October Investor Conferences
28 Sep 2023 //
GLOBENEWSWIRE
Nusano Appoints Industry Expert Alexandre Gibim as Chief Operations Officer
15 Sep 2023 //
GLOBENEWSWIRE
Nusano to Participate in Isotope and Radiopharmaceutical Conferences
20 Jul 2023 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.